RecruitingNCT07349251

Normal Hemostasis Values in Premature Infants

Sponsor

University Hospital, Strasbourg, France

Enrollment

1,000 participants

Start Date

Nov 24, 2025

Study Type

OBSERVATIONAL

Conditions

Premature Infant, Hemostasis

Summary

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Eligibility

Min Age: 0 MonthsMax Age: 18 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with premature infant, hemostasis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Months to 18 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Laboratoire d'Hématologie - CHU de Strasbourg - France

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07349251